Cas 1235581-88-0,methyl 3-(3,4-dihydroxyphenyl)-2-(2-(2-methoxy-4-(3-thioxo-3H-1,2-dithiol-5-yl)phenoxy)acetoamido)propanoate

1235581-88-0

Post Buying Request

Basic information

Product Name: methyl 3-(3,4-dihydroxyphenyl)-2-(2-(2-methoxy-4-(3-thioxo-3H-1,2-dithiol-5-yl)phenoxy)acetoamido)propanoate
Synonyms: methyl 3-(3,4-dihydroxyphenyl)-2-(2-(2-methoxy-4-(3-thioxo-3H-1,2-dithiol-5-yl)phenoxy)acetoamido)propanoate
CAS NO:1235581-88-0
Molecular Formula:
Molecular Weight: 507.609
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: methyl 3-(3,4-dihydroxyphenyl)-2-(2-(2-methoxy-4-(3-thioxo-3H-1,2-dithiol-5-yl)phenoxy)acetoamido)propanoate(CAS DataBase Reference)
NIST Chemistry Reference: methyl 3-(3,4-dihydroxyphenyl)-2-(2-(2-methoxy-4-(3-thioxo-3H-1,2-dithiol-5-yl)phenoxy)acetoamido)propanoate(1235581-88-0)
EPA Substance Registry System: methyl 3-(3,4-dihydroxyphenyl)-2-(2-(2-methoxy-4-(3-thioxo-3H-1,2-dithiol-5-yl)phenoxy)acetoamido)propanoate(1235581-88-0)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1235581-88-0(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1235581-88-0 Suppliers

Recommended suppliers

1235581-88-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1235581-88-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,3,5,5,8 and 1 respectively; the second part has 2 digits, 8 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1235581-88:
(9*1)+(8*2)+(7*3)+(6*5)+(5*5)+(4*8)+(3*1)+(2*8)+(1*8)=160
160 % 10 = 0
So 1235581-88-0 is a valid CAS Registry Number.

1235581-88-0Upstream product

1235581-88-0Downstream Products

1235581-88-0Relevant academic research and scientific papers

Effects of hydrogen sulfide-releasing L-DOPA derivatives on glial activation: Potential for treating Parkinson disease

Lee, Moonhee,Tazzari, Valerio,Giustarini, Daniela,Rossi, Ranieri,Sparatore, Anna,Del Soldato, Piero,McGeer, Edith,McGeer, Patrick L.

experimental part, p. 17318 - 17328 (2011/05/06)

The main lesion in Parkinson disease (PD) is loss of substantia nigra dopaminergic neurons. Levodopa (L-DOPA) is the most widely used therapy, but it does not arrest disease progression. Some possible contributing factors to the continuing neuronal loss a

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1235581-88-0